TECX · CIK 0001681087 · operating
Tectonic Therapeutic, Inc. (TECX) is a biological products, (no diagnostic substances) company incorporated in NY, listed on the Nasdaq. With a market capitalization of $430 million, Tectonic Therapeutic, Inc. is a small-cap company. The stock currently trades at $23.00, down 1.92% today, with a 52-week range of $13.70–$27.33.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-4.05 | $-4.05 | +40.7% | |
| 2024 | $-6.83 | $-6.83 | -2629.6% | |
| 2023 | $0.27 | $0.27 | +111.2% | |
| 2022 | $-2.42 | $-2.42 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-26 | 0001193125-26-076793 | SEC ↗ |
| 2024-12-31 | 2025-03-20 | 0000950170-25-042648 | SEC ↗ |
| 2023-12-31 | 2024-03-14 | 0000950170-24-031635 | SEC ↗ |
| 2022-12-31 | 2023-03-23 | 0000950170-23-009527 | SEC ↗ |
| 2021-12-31 | 2022-03-17 | 0001564590-22-010895 | SEC ↗ |
| 2020-12-31 | 2021-03-18 | 0001564590-21-014190 | SEC ↗ |
| 2019-12-31 | 2020-03-16 | 0001564590-20-011144 | SEC ↗ |
| 2018-12-31 | 2019-03-25 | 0001193125-19-085321 | SEC ↗ |